Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL107913 | 0.97 | ALDH1A1 (0.35) | HSD17B10ALDH1A1LMNATSHRCHRM1 | |
| Ether SCHEMBL3377966 | 0.85 | CHRM1 (0.41) | HSD17B10ALDH1A1LMNATSHRCHRM1 | |
| Glycerin SCHEMBL1680069 | 0.85 | LMNA (0.41) | ALDH1A1LMNATSHR | |
| Ammonia Solution, Strong SCHEMBL5513642 | 0.85 | — | — | |
| Ether SCHEMBL9888367 | 0.84 | HSD17B10 (0.52) | HSD17B10TSHRTDP1 | |
| Ether SCHEMBL23130890 | 0.82 | ALDH1A1 (0.42) | HSD17B10ALDH1A1LMNATSHRCHRM1 | |
| SCHEMBL28703 | 0.82 | — | — | |
| SCHEMBL11142874 | 0.82 | TSHR (0.42) | ALDH1A1LMNATSHRCHRM1AKR1A1 | |
| Ether SCHEMBL8168048 | 0.81 | ALDH1A1 (0.37) | ALDH1A1TSHR | |
| Ethyl Acetate SCHEMBL143987 | 0.80 | ALDH1A1 (0.56) | HSD17B10ALDH1A1LMNATSHRCHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2238206-B1 | CHROMATE-FREE CORROSION PROTECTION FOR FUEL TANKS | MANKIEWICZ GEBR & CO GMBH & CO KG (DE) | 2020-04-01 | — | — | EP | disclosed |
| US-9279055-B2 | Chromate-free corrosion protection for fuel tanks | MANKIEWICZ GEBR. & CO. GMBH & CO. KG (DE) | 2016-03-08 | — | — | US | disclosed |
| US-20110124738-A1 | CHROMATE-FREE CORROSION PROTECTION FOR FUEL TANKS | AIRBUS OPERATIONS GMBH (DE) | 2011-05-26 | — | — | US | disclosed |
| US-20100285311-A1 | Dual component (aqueous) hybrid reactive resin system, method for production and use thereof | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2010-11-11 | — | — | US | disclosed |
| US-5214124-A | With oleic and isostearic acids and ethylenediamine, for relief printing | SCHERING AG (DE) | 1993-05-25 | — | — | US | disclosed |
| US-4966945-A | ROOM TEMPERATURE CURING OF A POLYEPOXIDE AND CARBOXYL-CONTAIN ING POLYMER AFTER EVAPORATION OF AN AQUEOU SOLVENT; FILMS HAVING GOOD ADHESION AND WEAR RESISTANCE; FLEXOGRAPHY | SCHERING AG (DE) | 1990-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124738-A1 | CHROMATE-FREE CORROSION PROTECTION FOR FUEL TANKS | TANK, CA7, CA2 | HSD17B10 3389/4885ALDH1A1 3416/4885LMNA 4467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.